Discover 570 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma City offers many opportunities for both healthy volunteers and individuals with specific health concerns to participate in clinical research. Participants have the opportunity to explore innovative treatments and contribute to the advancement of medical science for conditions such as depression, pulmonary fibrosis, and various neurological disorders.
Filter
2
Filter results
Results: 570
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Oklahoma City OK, Tulsa OK, McKinney TX, Lewisville TX,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase3, Recruiting
Travoprost Intraocular Implant + iStent Infinite
for
Glaucoma, Open-Angle
Location: Oklahoma City OK
Sponsor: Glaukos Corporation
Sex: All
Age: 18+
Code: NCT06066645
Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Oklahoma City OK, Dallas TX, Kansas City MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase3, Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
for
Eosinophilic Asthma
Location: Oklahoma City OK, McKinney TX, San Antonio TX,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 70+
Code: NCT06750289
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Oklahoma City OK, El Dorado KS, Paris TX, Newton KS,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Oklahoma City OK, Norman OK, Tulsa OK, Wichita KS,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
for
Palmoplantar Pustulosis
Location: Oklahoma City OK, Birmingham AL, Fairborn OH,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07219420
Phase3, Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Oklahoma City OK, Dallas TX, Saint Joseph MO,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase3, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Oklahoma City OK, Dallas TX, Louisville KY,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase3, Recruiting
Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy
for
Radiculopathy Lumbar, Radiculopathy Sacral,
Location: Edmond OK, El Paso TX, Shepherdsville KY, Bardstown KY,
Sponsor: NeuFit - Neurological Fitness and Education
Sex: All
Age: 18+
Code: NCT06421558
Recruiting
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
for
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis,
Location: Oklahoma City OK, Baton Rouge LA, Indianapolis IN,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07332091
Phase2, Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Location: Oklahoma City OK, Dallas TX, Red Oak TX, Temple TX,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06072482
Recruiting
SELUTION4BTK Trial
for
Peripheral Arterial Disease,
Location: Oklahoma City OK, Tyler TX, Jonesboro AR,
Sponsor: M.A. Med Alliance S.A.
Sex: All
Age: 18+
Code: NCT05055297
Recruiting
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Oklahoma City OK, Dallas TX, Kansas City KS, Lincoln NE,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT07143669
Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Oklahoma City OK, San Antonio TX, Bowling Green KY,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT07266402
Phase3, Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
for
Chronic Spontaneous Urticaria
Location: Oklahoma City OK, Little Rock AR, Austin TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07219615
Phase2, Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for
Chronic Rhinosinusitis Without Nasal Polyps
Location: Oklahoma City OK, Tulsa OK, Austin TX, San Antonio TX,
Sponsor: Optinose US Inc.
Sex: All
Age: 12 - 17
Code: NCT06850805
Phase3, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Oklahoma City OK, Fort Smith AR, Dallas TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase3, Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
for
Mitral Regurgitation, Mitral Valve Disease,
Location: Oklahoma City OK, Houston TX, Minneapolis MN, Tucson AZ,
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Sex: All
Age: 18+
Code: NCT04688190
Recruiting
Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)